NewGenIvf Group Limited NIVF · Stock Open NewGenIvf Group Limited in new tab

0.5610 USD

Add to portfolio

P/E

0.02

EPS

36.48

P/B

0.01

ROE

79.40

Beta

-0.08

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for NewGenIvf Group Limited (NIVF)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

NewGenIvf Group Limited Analysis (NIVF)

Official Website Stock

Is NewGenIvf Group Limited a good investment? NewGenIvf Group Limited (NIVF) is currently trading at 0.5610 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.02. This relatively low multiple may signal that NewGenIvf Group Limited is undervalued compared to historical market norms.

Earnings Schedule: NewGenIvf Group Limited is expected to release its next earnings report on June 30, 2026. The market consensus estimate for Forward EPS is 9.34.

Investor FAQ

Does NewGenIvf Group Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is NewGenIvf Group Limited?

NewGenIvf Group Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be June 30, 2026. The company currently has a trailing EPS of 36.48.

Company Profile

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Exchange Ticker

NIVF

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
May 5, 2025	0.100000
Aug. 4, 2025	0.200000
March 16, 2026	0.250000
Dec. 3, 2025	0.200000
Dec. 1, 2025	0.200000
Jan. 26, 2026	0.330000
Feb. 11, 2025	0.050000

Fundamentals

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.